JDP to Present at Early Stage East 2009 Venture Conference (Princeton, NJ)
November 25, 2009
LANSDALE, PENNSYLVANIA, November 25, 2009 – JDP Therapeutics, Inc., a specialty pharmaceutical company developing innovative products for acute care in the hospital setting, today announced that Dr. Jie Du, President and CEO, will present at the Early Stage East 2009 Venture Conference on Wednesday, December 9th. The conference will be held in Nassau Inn in Princeton, NJ from December 8 – 9, 2009.
Dr. Du will provide an overview of the company and JDP’s innovative acute care products for the treatment of allergic reactions. She will also provide brief information on the company’s funding and exit strategies. Following the presentation, Dr. Du will be available for questions from the audience.
Early Stage East is geographically the largest venture conference specifically for early stage companies. Early Stage East hosts a variety of events and conferences including the trademarked Early Stage East (ESE) Venture Capital Conference, and Bio-Life-Tech (BLT) its life-science oriented venture capital conference. The Bio-Life-Tech Conference focuses on companies in the fields of Biotechnology, Pharmaceuticals, Healthcare Services, Medical Devices, Diagnostic Devices, Bioinformatics, Nanotechnology, Biomaterials, Nutraceuticals, Tissue Engineering, Genomics, Phytogenetics, Protemonics, Information Technology and related fields. Early Stage East has a long-standing tradition of providing entrepreneurial education programs to entrepreneurs and companies looking to build a great business.
For further information, please call 215-661-8557 or email info@jdptherapeutics.com.